Invest in

Fighting Fat

17.8%
0.5%
1.9%

Losing Weight – By Any Means Necessary

More than one-third of the US population is now officially obese (a body-mass index over 30) – a ratio that has tripled since 1960.[1] Meanwhile, the number of morbidly obese people has risen 350% in the past 3 decades.[5] Obesity contributes to many of the country’s serious health issues, from coronary disease, to diabetes to cancer, which results in close to 112,000 preventable deaths[2] while eating up 21% of US medical spending each year.[3] As big as US citizens are getting, the roster of companies joining the fight against obesity is also growing, with one weight-loss drug, Qysmia, expected to reach $2 billion in annual sales by 2017.[4] Whether companies are selling pharmaceuticals, surgeries or diet plans, fighting fat is literally big business. See more
17.8%
0.5%
1.9%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Fighting Fat Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
57.8% Diabetes Care 6.7%
21.1% Novo-Nordisk A/S ADR NVO 2.6%
17.9% Sanofi ADR (Sponsored) SNY 13.6%
11.2% Merck & Co. Inc MRK 3.4%
3.4% Astrazeneca Plc ADR AZN 11.0%
2.2% Alkermes plc ALKS 27.9%
2.0% Greatbatch Inc GB 31.9%
32.9% Weight Management 8.0%
12.7% NutriSystem Inc NTRI 15.2%
7.8% Medifast Inc MED 4.2%
4.2% Weight Watchers International Inc. WTW 61.9%
2.3% Nu Skin Enterprises Inc. (A) NUS 30.3%
2.1% GNC Holdings Inc GNC 44.9%
2.0% USANA Health Sciences Inc. USNA 1.8%
1.9% Vitamin Shoppe VSI 33.6%
9.3% Weight Loss Drugs 63.6%
8.1% Arena Pharmaceuticals Inc. ARNA 59.0%
1.2% Orexigen Therapeutics Inc. OREX 93.3%

Quotes delayed 15 mins. Currently Apr 30, 2016 3:09:36 AM. Fields are marked with -- when data is unavailable.